SE427238B - SET TO INSULATE INFLUENCEVIRUS SUBSTANCES - Google Patents

SET TO INSULATE INFLUENCEVIRUS SUBSTANCES

Info

Publication number
SE427238B
SE427238B SE7500130A SE7500130A SE427238B SE 427238 B SE427238 B SE 427238B SE 7500130 A SE7500130 A SE 7500130A SE 7500130 A SE7500130 A SE 7500130A SE 427238 B SE427238 B SE 427238B
Authority
SE
Sweden
Prior art keywords
influencevirus
insulate
substances
insulate influencevirus
influencevirus substances
Prior art date
Application number
SE7500130A
Other languages
Swedish (sv)
Other versions
SE7500130L (en
Inventor
H Bachmayer
G Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7500130L publication Critical patent/SE7500130L/
Publication of SE427238B publication Critical patent/SE427238B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
SE7500130A 1974-01-14 1975-01-07 SET TO INSULATE INFLUENCEVIRUS SUBSTANCES SE427238B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
SE7500130L SE7500130L (en) 1975-07-15
SE427238B true SE427238B (en) 1983-03-21

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500130A SE427238B (en) 1974-01-14 1975-01-07 SET TO INSULATE INFLUENCEVIRUS SUBSTANCES

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
NZ567817A (en) * 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Nanotherapeutics, Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Also Published As

Publication number Publication date
DK140003B (en) 1979-06-05
FR2257305A1 (en) 1975-08-08
YU41289B (en) 1987-02-28
HK56380A (en) 1980-10-16
JPS58407B2 (en) 1983-01-06
NL166622C (en) 1981-09-15
FR2257305B1 (en) 1982-03-19
ES433759A1 (en) 1977-02-16
NO143128B (en) 1980-09-15
BE824372A (en) 1975-07-14
AU7730575A (en) 1976-07-15
CS191254B2 (en) 1979-06-29
MY8100204A (en) 1981-12-31
YU5875A (en) 1984-04-30
DE2500785A1 (en) 1975-07-31
HU173920B (en) 1979-09-28
GB1498261A (en) 1978-01-18
DK140003C (en) 1979-10-29
PH14458A (en) 1981-07-29
FI750014A (en) 1975-07-15
DE2500785B2 (en) 1980-01-03
SU616997A3 (en) 1978-07-25
FI54053C (en) 1978-10-10
NL166622B (en) 1981-04-15
SE7500130L (en) 1975-07-15
DD116239A5 (en) 1975-11-12
JPS56127319A (en) 1981-10-06
PL93689B1 (en) 1977-06-30
NO750031L (en) 1975-08-11
IL46426A (en) 1978-01-31
DE2500785C3 (en) 1980-09-11
JPS6035326B2 (en) 1985-08-14
CH589453A5 (en) 1977-07-15
AT345449B (en) 1978-09-11
AU500250B2 (en) 1979-05-17
IL46426A0 (en) 1975-04-25
NO143128C (en) 1980-12-29
ZA75259B (en) 1976-08-25
IE40794B1 (en) 1979-08-15
IE40794L (en) 1975-07-14
DK1475A (en) 1975-09-01
FI54053B (en) 1978-06-30
CA1049406A (en) 1979-02-27
NL7500301A (en) 1975-07-16
ATA21475A (en) 1978-01-15
JPS50100224A (en) 1975-08-08

Similar Documents

Publication Publication Date Title
SE7512087L (en) WAY TO PRODUCE WATERWELLABLE POLYALKYLENOXIDE
SE430887B (en) SET TO MAKE SOME SUBSTITUTED PHENYLGUANIDINES
SE417507B (en) SET TO PREPARE 2-ARYLAMINO-2-IMIDAZOLINE DERIVATIVES
SE420602B (en) SET TO PREPARE PYRAZINE-3-METOXI-2-CARBOXAMIDE DERIVATIVES
SE407944B (en) WAY TO PRODUCE COKE
IT1048346B (en) PROCEDURE TO PRODUCE STIROLO
SE427238B (en) SET TO INSULATE INFLUENCEVIRUS SUBSTANCES
SE399270B (en) WAY TO PRODUCE SPIROLACTONSTEROIDS
SE381252B (en) WAY TO PRODUCE CONTACT BODIES
SE7506037L (en) WAY TO PRODUCE STABLE CONDENSATION PRODUCTS
SE427930B (en) SET TO RECOVER ORGANOTENNHALOGENIDES
SE7509513L (en) WAY TO PRODUCE BIETAMIDE DERIVATIVES
SE7508561L (en) PROCEDURE TO PRODUCE ALFA-AZIDOBENZYLPENICILLIN
SE7506036L (en) WAY TO PRODUCE STABLE CONDENSATION PRODUCTS
SE7506038L (en) WAY TO PRODUCE STABLE CONDENSATION PRODUCTS
SE7506571L (en) WAY TO PRODUCE NEW BUFATRIENOLIDRAMNOSIDES
SE406316B (en) WAY TO MANUFACTURE ALUMINUM OXIDWHISKERS
SE422336B (en) SET TO MAKE SILICONE
SE7510276L (en) BRUSH JEMTE WAY TO PRODUCE ONE SUCH
JPS5118654A (en) KAJITSUYOWATSUKUSUNO TO FUSOCHI
SE7514519L (en) WAY TO PRODUCE LAMINATE TILES
SE420722B (en) SET TO PREPARE BENZHYDRYLOXY-ALKYLAMINE DERIVATIVES
SE384967B (en) WAY TO PRODUCE CARIES INHIBITANT SUGAROSE
SE7511825L (en) VERMEXLARTERUB AND WAY TO PRODUCE THIS
JPS5139180A (en) HYOSENNOIDOOTSUISEKISURUHOHO TO SONOSOOCHI

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500130-5

Effective date: 19940810

Format of ref document f/p: F